IL299212A - Preparations for the treatment of respiratory arrest during sleep - Google Patents
Preparations for the treatment of respiratory arrest during sleepInfo
- Publication number
- IL299212A IL299212A IL299212A IL29921222A IL299212A IL 299212 A IL299212 A IL 299212A IL 299212 A IL299212 A IL 299212A IL 29921222 A IL29921222 A IL 29921222A IL 299212 A IL299212 A IL 299212A
- Authority
- IL
- Israel
- Prior art keywords
- minutes
- thc
- pharmaceutically acceptable
- acceptable salt
- carbonic anhydrase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020902368A AU2020902368A0 (en) | 2020-07-09 | A method of treatment | |
| PCT/AU2021/050734 WO2022006636A1 (en) | 2020-07-09 | 2021-07-09 | Compositions and methods for the treatment of obstructive sleep apnoea (osa) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL299212A true IL299212A (en) | 2023-02-01 |
Family
ID=79553355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL299212A IL299212A (en) | 2020-07-09 | 2021-07-09 | Preparations for the treatment of respiratory arrest during sleep |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230310364A1 (https=) |
| EP (1) | EP4178568A4 (https=) |
| JP (1) | JP7796718B2 (https=) |
| AU (1) | AU2021306424A1 (https=) |
| CA (1) | CA3182528A1 (https=) |
| CO (1) | CO2023000118A2 (https=) |
| IL (1) | IL299212A (https=) |
| WO (1) | WO2022006636A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025520386A (ja) * | 2022-06-21 | 2025-07-03 | アプニメッド，インコーポレイテッド（デラウェア） | カンナビノイドおよびカルボニックアンヒドラーゼ阻害剤の組合せを用いた睡眠時無呼吸を治療する方法 |
| EP4626410A1 (en) * | 2022-11-29 | 2025-10-08 | Incannex Healthcare Limited | A method of treating obstructive sleep apnoea (osa) |
| WO2025107039A1 (en) * | 2023-11-23 | 2025-05-30 | Incannex Healthcare Limited | Composition comprising tetrahydrocannabinol and acetazolamide in a fixed dose combination capsule |
| WO2025191322A1 (en) * | 2024-03-11 | 2025-09-18 | Mousavi Mirzaei Seyed Mohammad | Therapeutic composition for improving symptoms of obstructive sleep apnea |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3090743A1 (en) * | 2008-01-09 | 2016-11-09 | Charleston Laboratories, Inc. | Pharmaceutical compositions for treating headache and eliminating nausea |
| WO2019071302A1 (en) * | 2017-10-09 | 2019-04-18 | The University Of Sydney | METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING EPILEPSY CRISES |
| CA3126772A1 (en) * | 2018-01-29 | 2019-08-01 | Evero | Compositions and methods for treating obstructive sleep apnea |
| WO2019180706A1 (en) * | 2018-03-19 | 2019-09-26 | Bol Pharma Ltd. | Methods and compositions for treating epilepsy and associated disorders |
| US20240189328A1 (en) * | 2021-04-16 | 2024-06-13 | Apnimed, Inc. (Delaware) | Combination of norepinephrine reuptake inhibitor and a cannabinoid for use in treating sleep apnea |
-
2021
- 2021-07-09 WO PCT/AU2021/050734 patent/WO2022006636A1/en not_active Ceased
- 2021-07-09 US US18/000,880 patent/US20230310364A1/en active Pending
- 2021-07-09 EP EP21837113.6A patent/EP4178568A4/en active Pending
- 2021-07-09 JP JP2023501090A patent/JP7796718B2/ja active Active
- 2021-07-09 IL IL299212A patent/IL299212A/en unknown
- 2021-07-09 CA CA3182528A patent/CA3182528A1/en active Pending
- 2021-07-09 AU AU2021306424A patent/AU2021306424A1/en active Pending
-
2023
- 2023-01-06 CO CONC2023/0000118A patent/CO2023000118A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3182528A1 (en) | 2022-01-13 |
| EP4178568A1 (en) | 2023-05-17 |
| JP2023533289A (ja) | 2023-08-02 |
| WO2022006636A1 (en) | 2022-01-13 |
| CO2023000118A2 (es) | 2023-04-17 |
| JP7796718B2 (ja) | 2026-01-09 |
| AU2021306424A1 (en) | 2023-01-19 |
| EP4178568A4 (en) | 2024-10-16 |
| US20230310364A1 (en) | 2023-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL299212A (en) | Preparations for the treatment of respiratory arrest during sleep | |
| TWI819995B (zh) | 以加波沙朵（ｇａｂｏｘａｄｏｌ）治療發育障礙的方法 | |
| US20240131041A1 (en) | Use of cannabidivarin in the treatment of seizures associated with canine epilepsy | |
| KR20220145377A (ko) | 5ht2a 효능제 투여 후의 제어 효과 | |
| EP4497471A2 (en) | Stimulation of neuronal plasticity | |
| IL301910A (en) | Transcutaneous synthetic cannabidiol for the treatment of focal epilepsy in adults | |
| IL303388A (en) | Treatment of refractory convulsions | |
| RU2563821C2 (ru) | Применение 4-аминопиридина для улучшения состояния при нейрокогнитивном и/или нейропсихиатрическом нарушении у пациентов с демиелинизирующими и другими заболеваниями нервной системы | |
| AU2022259671A1 (en) | Combination of a norepinephrine reuptake inhibitor and a cannabinoid for use in treating sleep apnea | |
| CN114507205A (zh) | 二氢杨梅素四氢吡咯复合物及其制备方法和应用 | |
| EP4522271A1 (en) | Methods of use of t-type calcium channel modulators | |
| WO2023000247A1 (zh) | α-细辛脑在制备预防或治疗出血性脑卒中药物中的应用 | |
| Goswami et al. | Intranasal ketamine for acute pain: behavioral and neurophysiological safety analysis in mice | |
| IL305289A (en) | Use of cannabidiol and clobazam in the treatment of childhood-onset epilepsy syndromes | |
| EP4626410A1 (en) | A method of treating obstructive sleep apnoea (osa) | |
| Fantini et al. | Sleep and violence | |
| TWI739220B (zh) | 包含克拉維酸與丙戊酸之組合物及其用途 | |
| WO2025107039A1 (en) | Composition comprising tetrahydrocannabinol and acetazolamide in a fixed dose combination capsule | |
| KR20260056192A (ko) | 발작 치료 방법 | |
| CN107137391A (zh) | 二氢杨梅素在制备治疗抑郁症的药物方面的用途 | |
| WO2025208209A1 (en) | Use of ibogaine in the treatment of central nervous system stroke | |
| CN116782891A (zh) | 大麻二酚对难治性癫痫发作的治疗 | |
| JPWO2005027968A1 (ja) | ダウン症候群治療剤 | |
| Corquaye | Farmakoterapie bolesti |